Absci (ABSI) Common Equity (2020 - 2026)
Absci (ABSI) reported Common Equity of $172.0 million for Q1 2026, down 13.49% on a YoY basis from $198.8 million in Q1 2025, and down 9.23% sequentially from $189.4 million in Q4 2025.
Absci (ABSI) Common Equity (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Common Equity data on file, last reported at $172.0 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 13.49% year-over-year to $172.0 million; the trailing twelve-month figure through Mar 2026 stood at $172.0 million (down 13.49% YoY), and the FY2025 full-year result was $189.4 million, up 5.76% from the prior year.
- Common Equity slipped to $172.0 million in Q1 2026, from $189.4 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $340.5 million in Q1 2022 to a low of $172.0 million in Q1 2026.
- A 5-year average of $226.6 million and a median of $210.3 million in 2025 frame the typical range for Common Equity.
- Across the five-year window, Common Equity surged 445.67% in 2022 and tumbled 35.8% in 2023, its largest moves.
- Tracing ABSI's Common Equity over 5 years: stood at $274.4 million in 2022, then plunged by 35.8% to $176.2 million in 2023, then gained by 1.68% to $179.1 million in 2024, then advanced by 5.76% to $189.4 million in 2025, then decreased by 9.23% to $172.0 million in 2026.
- Business Quant data shows ABSI's Common Equity at $172.0 million in Q1 2026, $189.4 million in Q4 2025, and $210.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 171.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.97 Mn |
| Dec 31, 2025 | 189.45 Mn |
| Sep 30, 2025 | 210.34 Mn |
| Jun 30, 2025 | 173.37 Mn |
| Mar 31, 2025 | 198.80 Mn |
| Dec 31, 2024 | 179.13 Mn |
| Sep 30, 2024 | 201.34 Mn |
| Jun 30, 2024 | 221.49 Mn |
| Mar 31, 2024 | 240.11 Mn |
| Dec 31, 2023 | 176.18 Mn |
| Sep 30, 2023 | 196.42 Mn |
| Jun 30, 2023 | 215.40 Mn |
| Mar 31, 2023 | 253.97 Mn |
| Dec 31, 2022 | 274.41 Mn |
| Sep 30, 2022 | 292.94 Mn |
| Jun 30, 2022 | 316.19 Mn |
| Mar 31, 2022 | 340.50 Mn |
| Dec 31, 2021 | 366.11 Mn |
| Sep 30, 2021 | 388.01 Mn |
| Jun 30, 2021 | -124.26 Mn |